BDTX vs CSGP · $95.7M cap vs P/E 484, rev $2.74B
Black Diamond Therapeutics Inc (BDTX) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
Black Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
BDTX does not have a complete income-statement cache yet.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
BDTX currently screens at market cap $95.7M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the BDTX and CSGP stock pages for the full models.
Not investment advice.